ArticleBritish journal of cancer2012

Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation.

P Starlinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.